Joseph Jurcic
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP) (NCT05524857) | Joseph Jurcic | 2022-01-28 |
| Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia (NCT03705858) | Joseph Jurcic | 2019-02-28 |
Track Joseph Jurcic automatically
Every clearance here is in the API, with alerts when new ones post.